返回 Agenda
[V2-S5] Efforts to Raise Drug Literacy - How Should We Take Care It in Citizens Themselves Learn about Drugs - (Part1)
Session Chair(s)
Tomiko Tawaragi
Director, RAD-AR Council, Japan
Junichi Nishino, MSC, RPH
Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd., Japan
“The citizen must strive to deepen knowledge and understanding on the effectiveness and safety of these products as well as properly using medicines and the like” in the Pharmaceuticals and Medical Devices Law. Because of the spread of the Internet, information is flooded, but is it all reliable information? Is it possible to say that the information from the patient’s point of view is now enough prepared? The information that the patient sought is diverse and it is recommended to consult a doctor / pharmacist first, but in addition to that, highly reliable information that the patient themselves can obtain is also necessary. In this session, we will organize the current status of pharmaceutical information in Japan and introduce efforts and issues relating to providing information to patients from speakers with different positions In Part 2 of V2 - S6, experts from industry, government and academia will discuss the future directions of drug information provision in Japan on each side of those who prepare and provide drug information, patients, people who explain to patients, and PMDA.
Speaker(s)
Junichi Nishino, MSC, RPH
Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd., Japan
Current Situation and Issues for Providing Drug Information to Patients in Industries
Ikuko Yamaguchi
Board Chairperson, NPO COML, Japan
What Kind of Drug Information Are Needed by Patients? - Current Issues & Future Perspective from Patients Point of View -
Susumu Wakabayashi
Department of Pharmacy, Kyorin University Hospital, Japan
What Kind of Drug Information Are Needed by Patients? - Current Issues & Future Perspective from Pharmacist Point of View -
Kiyomi Ueno, PHD
Director, Office of Safety I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Current Situation and Issues for Providing Drug Information from PMDA to Patients